Pulse Biosciences (NASDAQ:PLSE) Upgraded to Sell at StockNews.com

StockNews.com upgraded shares of Pulse Biosciences (NASDAQ:PLSE) to a sell rating in a report issued on Monday morning.

Pulse Biosciences Stock Down 3.1 %

Shares of Pulse Biosciences stock opened at $16.09 on Monday. The stock’s fifty day moving average is $18.78 and its two-hundred day moving average is $18.15. Pulse Biosciences has a 52 week low of $6.60 and a 52 week high of $25.00.

Institutional Investors Weigh In On Pulse Biosciences

Several large investors have recently added to or reduced their stakes in the stock. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new stake in shares of Pulse Biosciences during the third quarter valued at approximately $588,000. Charles Schwab Investment Management Inc. raised its position in Pulse Biosciences by 193.0% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 148,114 shares of the company’s stock valued at $2,598,000 after purchasing an additional 97,565 shares in the last quarter. State Street Corp raised its position in Pulse Biosciences by 17.8% during the 3rd quarter. State Street Corp now owns 461,333 shares of the company’s stock valued at $8,092,000 after purchasing an additional 69,696 shares in the last quarter. Geode Capital Management LLC lifted its holdings in shares of Pulse Biosciences by 7.8% in the 3rd quarter. Geode Capital Management LLC now owns 457,165 shares of the company’s stock worth $8,020,000 after buying an additional 33,200 shares during the period. Finally, Franklin Resources Inc. bought a new position in shares of Pulse Biosciences during the 3rd quarter worth $378,000. 76.95% of the stock is owned by hedge funds and other institutional investors.

About Pulse Biosciences

Pulse Biosciences, Inc operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology.